Sep 20, 2017

Members of the National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council (MASAC) recently gathered during NHF’s 69th Annual Meeting on August 26, 2017 in Chicago. The meeting generated three new documents related to treatment, therapies, women with bleeding disorders, carriers and emergency room management. These documents, which are listed below, were subsequently adopted by NHF’s Board of Directors on September 17, 2017.

MASAC Document #250: MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders.

MASAC Document #251: MASAC Guidelines for Perinatal Management of Women with Bleeding Disorders and Carriers of Hemophilia A and B.

MASAC Document #252: Guidelines for Emergency Department Management of Individuals with Hemophilia and Other Bleeding Disorders.

Viiew the complete list of current MASAC documents. To request a hard copy of any current documents, please contact HANDI, NHF’s information resource center:  (link sends e-mail) or 1.800.424.2634.